{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T01:12:57Z","timestamp":1755825177869,"version":"3.44.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Neutral Lipid Storage Disease with Myopathy (NLSDM) is a rare lipid metabolism disorder caused by impaired Adipose Triglyceride Lipase (ATGL) activity, leading to neutral lipid accumulation in various tissues. It typically manifests with progressive skeletal myopathy, with an onset of around 35 years. In addition, some patients develop cardiomyopathy and liver dysfunction. Herein, we report the molecular characterization of a 27-year-old Hungarian patient and his family in whom two severe <jats:italic>PNPLA2<\/jats:italic> mutations led to complete loss of ATGL production in the patient\u2019s tissues. DNA sequencing revealed a nonsense (c.24G&amp;gt;A) and a frameshift mutation (c.798dupC) in the <jats:italic>PNPLA2<\/jats:italic> gene. RNA analysis showed nonsense-mediated decay of the c.798dupC transcript, while c.24G&amp;gt;A was normally expressed in the patient. However, Western blot analysis did not detect ATGL protein production. From a clinical perspective, our patient exhibited pes planus, proximal muscle weakness of the lower limbs and elevated CK levels from the age of six. MRI and biopsy revealed lipid accumulation, and leukocytes showed Jordans\u2019 anomaly. The muscle weakness progressed, and cardiomyopathy and hepatic steatosis were also observed recently. The case highlights two severe <jats:italic>PNPLA2<\/jats:italic> mutations leading to complete ATGL deficiency and an unusual early-onset myopathy in childhood.<\/jats:p>","DOI":"10.3389\/fgene.2025.1642442","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T04:10:36Z","timestamp":1755749436000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Pathogenic PNPLA2 variants and nonsense-mediated mRNA decay result in an early-onset neutral lipid storage disease with myopathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Sara","family":"Missaglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Martegani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Karcagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endre","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Tavian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5334\/ojb.15","article-title":"Galliera genetic bank: a DNA and cell line biobank from patients affected by genetic diseases","volume":"3","author":"Baldo","year":"2016","journal-title":"Open J. Bioresour."},{"key":"B2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.5483\/BMBRep.2023-0190","article-title":"Nonsense-mediated mRNA decay, a simplified view of a complex mechanism","volume":"56","author":"Carrard","year":"2023","journal-title":"BMB Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1161\/CIRCULATIONAHA.124.072194","article-title":"XBP1s-EDEM2 prevents the onset and development of HFpEF by ameliorating cardiac lipotoxicity","volume":"151","author":"Fonseka","year":"2025","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nmd.2023.07.007","article-title":"HyperCKemia: an early sign of childhood-onset neutral lipid storage disease with myopathy","volume":"33","author":"Fu","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1051\/medsci\/201632s203","article-title":"Myopathie \u00e0 surcharge lipidique secondaire \u00e0 une nouvelle mutation du g\u00e8ne PNPLA2","volume":"32","author":"Jousserand","year":"2016","journal-title":"Medecine\/Sciences"},{"key":"B7","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.nmd.2014.04.001","article-title":"A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review","volume":"24","author":"Kaneko","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ymgme.2012.12.004","article-title":"Neutral lipid storage disease with myopathy: a whole-body nuclear MRI and metabolic study","volume":"108","author":"Lafor\u00eat","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/biomedicines10010141","article-title":"Nonsense-mediated mRNA decay, a finely regulated mechanism","volume":"10","author":"Lejeune","year":"2022","journal-title":"Biomedicines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mrrev.2014.05.001","article-title":"Nonsense-mediated decay in genetic disease: friend or foe?","volume":"762","author":"Miller","year":"2014","journal-title":"Mutat. Res. - Rev. Mutat. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/cells8020187","article-title":"Neutral lipid storage diseases as cellular model to study lipid droplet function","volume":"8","author":"Missaglia","year":"2019","journal-title":"Cells"},{"key":"B12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nmd.2017.01.011","article-title":"Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement","volume":"27","author":"Missaglia","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"10645","DOI":"10.4081\/ejtm.2022.10645","article-title":"Neutral lipid storage disease with myopathy: a 10-year follow-up case report","volume":"32","author":"Missaglia","year":"2022","journal-title":"Eur. J. Transl. Myol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijcard.2016.01.137","article-title":"Severe cardiomyopathy in a young patient with complete deficiency of adipose triglyceride lipase due to a novel mutation in PNPLA2 gene","volume":"207","author":"Pasanisi","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13023-017-0646-9","article-title":"Neutral lipid storage diseases: clinical\/genetic features and natural history in a large cohort of Italian patients","volume":"12","author":"Pennisi","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000508346","article-title":"Neutral lipid storage disease associated with the PNPLA2 gene: case report and literature review","volume":"83","author":"Samukawa","year":"2020","journal-title":"Eur. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bbalip.2018.10.008","article-title":"Of mice and men: the physiological role of adipose triglyceride lipase (ATGL)","volume":"1864","author":"Schreiber","year":"2019","journal-title":"Biochim. Biophys. Acta - Mol. Cell. Biol. Lipids"},{"key":"B18","doi-asserted-by":"publisher","first-page":"E289","DOI":"10.1152\/ajpendo.00099.2009","article-title":"Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase\/PNPLA2 or CGI-58\/ABHD5","volume":"297","author":"Schweiger","year":"2009","journal-title":"Am. J. Physiol. - Endocrinol. Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"554724","DOI":"10.3389\/fnint.2020.554724","article-title":"Case report: PNPLA2 gene complex heterozygous mutation leading to neutral lipid storage disease with myopathy","volume":"14","author":"Shi","year":"2021","journal-title":"Front. Integr. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.gendis.2019.07.006","article-title":"A novel PNPLA2 mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathy","volume":"8","author":"Tavian","year":"2021","journal-title":"Genes. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1093\/hmg\/dds388","article-title":"Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity May preserve cardiac function","volume":"21","author":"Tavian","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1415156","DOI":"10.3389\/fgene.2024.1415156","article-title":"Dilated cardiomyopathy caused by mutation of the PNPLA2 gene: a case report and literature review","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"107670","DOI":"10.1016\/j.clineuro.2023.107670","article-title":"Neutral lipid storage disease with myopathy with a novel homozygous PNPLA2 variant","volume":"228","author":"Yamada","year":"2023","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13023-019-1209-z","article-title":"Neutral lipid storage disease with myopathy in China: a large multicentric cohort study","volume":"14","author":"Zhang","year":"2019","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1642442\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T04:10:41Z","timestamp":1755749441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1642442\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":24,"alternative-id":["10.3389\/fgene.2025.1642442"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1642442","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"article-number":"1642442"}}